HUP0303151A2 - Biotin aminoszármazékai és ezek makrociklusos kelátképző szerekkel képzett konjugátumai - Google Patents
Biotin aminoszármazékai és ezek makrociklusos kelátképző szerekkel képzett konjugátumaiInfo
- Publication number
- HUP0303151A2 HUP0303151A2 HU0303151A HUP0303151A HUP0303151A2 HU P0303151 A2 HUP0303151 A2 HU P0303151A2 HU 0303151 A HU0303151 A HU 0303151A HU P0303151 A HUP0303151 A HU P0303151A HU P0303151 A2 HUP0303151 A2 HU P0303151A2
- Authority
- HU
- Hungary
- Prior art keywords
- hydrogen atom
- general formula
- aminoderivatives
- conjugates
- biotin
- Prior art date
Links
- 125000004057 biotinyl group Chemical class [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 title 1
- 239000002738 chelating agent Substances 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 7
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000002678 macrocyclic compounds Chemical class 0.000 abstract 1
- -1 p-aminophenyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
Abstract
A találmány (I) általános képletű vegyületekre, ezek radionuklidokkalképzett komplexeire és ezeket tartalmazó gyógyászati és diagnosztikaikészítményekre vonatkozik, amelyek a daganatterápiában hasznosak. Az(I) általános képletben a helyettesítők jelentése: Q jelentése -(CH2)n-, ahol n jelentése 4-12; -(CH2)a-CH(R')-(CH2)b-, ahol a és bjelentése 0-n; vagy ciklohexil- vagy fenilcsoport; R jelentésehidrogénatom vagy -L, ahol -L jelentése (II) általános képletűmakrociklus, ahol Y jelentése hidrogénatom, alkilcsoport, -(CH2)m-COOH, ahol m jelentése 1-3; X jelentése hidrogénatom vagy -CH2-U, aholU jelentése metil-, etil-, p-aminofenilcsoport, vagy X jelentése -(CHW)o-Z, ahol o jelentése 1-5, W jelentése hidrogénatom, metil- vagyetilcsoport, Z jelentése heterociklusos csoport; vagy -NH2, -NH-C(=NH)-NH2 vagy -S-R2, ahol R2 jelentése alkilcsoport; p értéke 2 vagy3, R' jelentése hidrogénatom, alkilcsoport, -(CH2)q-T, ahol Tjelentése -S-CH3, -OH vagy -COOH képletű csoport és q értéke 1 vagy 2;R< jelentése megegyezik R jelentésével az alábbi feltételekkel: haRjelentése -L, akkor R< jelentése hidrogénatom; ha R jelentésehidrogénatom, akkor R< jelentése -L, vagy R, illetve R< rendre -(CH2)r-L, ahol r értéke 4-12, illetve -L, Q jelentése -(CH2)n-, ahol njelentése 4-12. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001RM000079A ITRM20010079A1 (it) | 2001-02-16 | 2001-02-16 | Amminoderivati della biotina e loro coniugati con chelanti macrociclici. |
| PCT/IT2002/000091 WO2002066075A2 (en) | 2001-02-16 | 2002-02-15 | Biotin-derivatives and their conjugates with chelating agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0303151A2 true HUP0303151A2 (hu) | 2003-12-29 |
| HUP0303151A3 HUP0303151A3 (en) | 2010-01-28 |
| HU229160B1 HU229160B1 (hu) | 2013-09-30 |
Family
ID=11455227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0303151A HU229160B1 (hu) | 2001-02-16 | 2002-02-15 | Biotin aminoszármazékai és ezek makrociklusos kelátképzõ szerekkel képzett konjugátumai |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7390828B2 (hu) |
| EP (1) | EP1359943B1 (hu) |
| JP (1) | JP4469133B2 (hu) |
| KR (1) | KR100860062B1 (hu) |
| CN (1) | CN100457192C (hu) |
| AT (1) | ATE306283T1 (hu) |
| AU (1) | AU2002237517B2 (hu) |
| BR (1) | BR0207327A (hu) |
| CZ (1) | CZ305442B6 (hu) |
| DE (1) | DE60206599T2 (hu) |
| DK (1) | DK1359943T3 (hu) |
| ES (1) | ES2248522T3 (hu) |
| HK (1) | HK1068251A1 (hu) |
| HU (1) | HU229160B1 (hu) |
| IT (1) | ITRM20010079A1 (hu) |
| MX (1) | MXPA03007317A (hu) |
| PL (1) | PL202898B1 (hu) |
| SK (1) | SK286112B6 (hu) |
| WO (1) | WO2002066075A2 (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20030196A1 (it) * | 2003-04-24 | 2004-10-25 | Sigma Tau Ind Farmaceuti | Uso di reagenti per la preparazione di un medicamento |
| ITRM20040105A1 (it) * | 2004-02-27 | 2004-05-27 | Tecnogen Scpa | Anticorpo monoclonale antitenascina umana. |
| ITRM20050345A1 (it) | 2005-06-30 | 2007-01-01 | Sigma Tau Ind Farmaceuti | Sintesi di deossi-biotinil esametilen diammina-dota. |
| TWI381852B (zh) * | 2005-09-27 | 2013-01-11 | Sigma Tau Ind Farmaceuti | 生物素二胺基衍生物類及其與大環螯合劑之共軛物 |
| CN101970497B (zh) | 2007-04-04 | 2017-05-10 | 希格马托制药工业公司 | 抗‑EpCAM抗体及其用途 |
| GB0922369D0 (en) * | 2009-12-22 | 2010-02-03 | Hammersmith Imanet Ltd | Labelled biotin conjugates |
| KR20140021520A (ko) * | 2010-10-22 | 2014-02-20 | 위니베르시떼 드 스트라스부르 | Hsp90 관련 질환의 치료에 유용한 포코옥심 컨쥬게이트 |
| DK2739314T3 (da) | 2011-08-02 | 2019-06-24 | Alfasigma Spa | Farmaceutisk sammensætning af oxideret avidin, der er egnet til inhalation |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6075010A (en) * | 1992-06-09 | 2000-06-13 | Neorx Corporation | Small molecular weight ligand-hexose containing clearing agents |
| US6416738B1 (en) * | 1973-12-07 | 2002-07-09 | Neorx Corporation | Pretargeting methods and compounds |
| US5283342A (en) * | 1992-06-09 | 1994-02-01 | Neorx Corporation | Biotinylated small molecules |
| DE3713842A1 (de) * | 1987-04-22 | 1988-11-17 | Schering Ag | Substituierte cyclische komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel |
| IT1245748B (it) | 1990-12-21 | 1994-10-14 | Mini Ricerca Scient Tecnolog | Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego |
| US5624896A (en) * | 1992-06-09 | 1997-04-29 | Neorx Corporation | Clearing agents useful in pretargeting methods |
| US5578287A (en) * | 1992-06-09 | 1996-11-26 | Neorx Corporation | Three-step pretargeting methods using improved biotin-active agent |
| US6358490B2 (en) * | 1992-06-09 | 2002-03-19 | Neorx Corporation | Three-step pretargeting methods and compounds |
| DE69331319T2 (de) * | 1992-06-09 | 2002-08-08 | Neorx Corp | Biotin-DOTA Konjugate und deren Verwendung in "Pretargeting" Verfahren |
| US5976535A (en) * | 1992-06-09 | 1999-11-02 | Neorx Corporation | Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore |
| US5541287A (en) * | 1992-06-09 | 1996-07-30 | Neorx Corporation | Pretargeting methods and compounds |
| US5914312A (en) * | 1992-06-09 | 1999-06-22 | Neorx Corporation | Pretargeting methods and compounds |
| US6217869B1 (en) * | 1992-06-09 | 2001-04-17 | Neorx Corporation | Pretargeting methods and compounds |
| US5616690A (en) * | 1992-06-09 | 1997-04-01 | Neorx Corporation | Hexose derivatized human serum albumin clearing agents |
| US5911969A (en) * | 1992-06-09 | 1999-06-15 | Neorx Corporation | Pretargeting protocols for enhanced localization of active agents to target sites |
| US6120768A (en) * | 1993-05-17 | 2000-09-19 | Immunomedics, Inc. | Dota-biotin derivatives |
| JPH0730748U (ja) * | 1993-11-29 | 1995-06-13 | 花王株式会社 | 歯ブラシ |
| US5955605A (en) * | 1995-02-21 | 1999-09-21 | Neorx Corporation | Biotinidase resistant biotin-DOTA conjugates |
| JPH11513374A (ja) * | 1995-09-18 | 1999-11-16 | マリンクロッド・メディカル・インコーポレイテッド | （放射性）標識化ビオチン誘導体類 |
| JP3427871B2 (ja) * | 1996-06-24 | 2003-07-22 | 戸田工業株式会社 | コバルト被着型針状磁性酸化鉄粒子粉末 |
| US6005083A (en) | 1997-03-28 | 1999-12-21 | Neorx Corporation | Bridged aromatic substituted amine ligands with donor atoms |
-
2001
- 2001-02-16 IT IT2001RM000079A patent/ITRM20010079A1/it unknown
-
2002
- 2002-02-15 JP JP2002565633A patent/JP4469133B2/ja not_active Expired - Fee Related
- 2002-02-15 AT AT02703851T patent/ATE306283T1/de active
- 2002-02-15 US US10/468,075 patent/US7390828B2/en not_active Expired - Lifetime
- 2002-02-15 DK DK02703851T patent/DK1359943T3/da active
- 2002-02-15 AU AU2002237517A patent/AU2002237517B2/en not_active Ceased
- 2002-02-15 ES ES02703851T patent/ES2248522T3/es not_active Expired - Lifetime
- 2002-02-15 BR BR0207327-7A patent/BR0207327A/pt not_active IP Right Cessation
- 2002-02-15 CZ CZ2003-1989A patent/CZ305442B6/cs not_active IP Right Cessation
- 2002-02-15 SK SK1115-2003A patent/SK286112B6/sk not_active IP Right Cessation
- 2002-02-15 CN CNB02805086XA patent/CN100457192C/zh not_active Expired - Fee Related
- 2002-02-15 KR KR1020037010689A patent/KR100860062B1/ko active IP Right Grant
- 2002-02-15 HU HU0303151A patent/HU229160B1/hu not_active IP Right Cessation
- 2002-02-15 MX MXPA03007317A patent/MXPA03007317A/es active IP Right Grant
- 2002-02-15 EP EP02703851A patent/EP1359943B1/en not_active Expired - Lifetime
- 2002-02-15 PL PL365279A patent/PL202898B1/pl unknown
- 2002-02-15 WO PCT/IT2002/000091 patent/WO2002066075A2/en active IP Right Grant
- 2002-02-15 DE DE60206599T patent/DE60206599T2/de not_active Expired - Lifetime
-
2005
- 2005-01-13 HK HK05100340.2A patent/HK1068251A1/xx not_active IP Right Cessation
-
2007
- 2007-11-27 US US11/987,060 patent/US8044081B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002066075A2 (en) | 2002-08-29 |
| CZ20031989A3 (cs) | 2004-02-18 |
| HK1068251A1 (en) | 2005-04-29 |
| CN100457192C (zh) | 2009-02-04 |
| BR0207327A (pt) | 2004-02-10 |
| HU229160B1 (hu) | 2013-09-30 |
| ES2248522T3 (es) | 2006-03-16 |
| CN1531445A (zh) | 2004-09-22 |
| US20040067199A1 (en) | 2004-04-08 |
| AU2002237517B2 (en) | 2006-11-30 |
| CZ305442B6 (cs) | 2015-09-23 |
| MXPA03007317A (es) | 2004-06-30 |
| ATE306283T1 (de) | 2005-10-15 |
| DK1359943T3 (da) | 2006-01-02 |
| JP2004524305A (ja) | 2004-08-12 |
| KR20030072627A (ko) | 2003-09-15 |
| ITRM20010079A1 (it) | 2002-08-16 |
| US20080085239A1 (en) | 2008-04-10 |
| EP1359943B1 (en) | 2005-10-12 |
| JP4469133B2 (ja) | 2010-05-26 |
| SK286112B6 (sk) | 2008-03-05 |
| US8044081B2 (en) | 2011-10-25 |
| DE60206599D1 (de) | 2005-11-17 |
| HUP0303151A3 (en) | 2010-01-28 |
| PL365279A1 (en) | 2004-12-27 |
| DE60206599T2 (de) | 2006-06-22 |
| WO2002066075A3 (en) | 2003-01-30 |
| ITRM20010079A0 (it) | 2001-02-16 |
| SK11152003A3 (sk) | 2004-02-03 |
| EP1359943A2 (en) | 2003-11-12 |
| KR100860062B1 (ko) | 2008-09-24 |
| US7390828B2 (en) | 2008-06-24 |
| PL202898B1 (pl) | 2009-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9800867A (es) | Halogenobencimidazoles y su empleo como microbicidas. | |
| ES8401032A1 (es) | Procedimiento para la obtencion de 1,4-dihidropiridinas. | |
| MX9604020A (es) | Arilalquildiazinonas. | |
| DE69425162D1 (de) | 4,5-diaryloxazol-derivate | |
| TW282456B (hu) | ||
| MY108261A (en) | Water soluble camptothecin derivatives | |
| CA2256582A1 (en) | Oxa acids and related compounds for treating skin conditions | |
| HK1016177A1 (en) | New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency | |
| GEP20033001B (en) | Alkynyl-Substituted Quinolin-2-One Derivatives Useful As Anticancer Agents | |
| IL132107A0 (en) | Substituted phenyl derivatives their preparation and use | |
| IE883844L (en) | Macrocyclic chelating agents and chelates thereof | |
| MX9800577A (es) | Derivados de 4,5-diaril oxazol. | |
| BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
| MX9504287A (es) | Derivados de camptotecina y proceso para su preparacion. | |
| HUP9802290A2 (hu) | Pirrolszármazékok és az azokat tartalmazó gyógyászati kompozíciók | |
| HUP9902017A2 (hu) | Aminosav- és hidroxisav-származékokkal szubsztituált benzamidinszármazékok és antikoagulánsokként történő alkalmazásuk | |
| WO1999050269A3 (de) | Porphyrine und ihre verwendung als phptosensitizer | |
| HUP0303151A2 (hu) | Biotin aminoszármazékai és ezek makrociklusos kelátképző szerekkel képzett konjugátumai | |
| TR199701287T1 (xx) | Azasikloalkan t�revleri, haz�rlan��lar� ve terapideki uygulamalar�. | |
| WO2002000638A8 (en) | Substituted phthalides as anti-convulsive drugs | |
| EP0774462A4 (en) | HETEROCYCLIC COMPOUND | |
| MX9702203A (es) | Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida. | |
| CA2262997A1 (en) | Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells | |
| IE893956L (en) | Novel compounds | |
| DE69431471D1 (de) | Amide derivate als 5-ht1a liganden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: ALFASIGMA S.P.A., IT Free format text: FORMER OWNER(S): SIGMA-TAU INDUSTRIE FARMACEUTICHE RINNITE S.P.A., IT |
|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |